DK352077A - Fremgangsmade til fremstilling af 1,5-disubstituerede 2-pyrrolidoner og mellemprodukter til anvendelse herved - Google Patents

Fremgangsmade til fremstilling af 1,5-disubstituerede 2-pyrrolidoner og mellemprodukter til anvendelse herved

Info

Publication number
DK352077A
DK352077A DK352077A DK352077A DK352077A DK 352077 A DK352077 A DK 352077A DK 352077 A DK352077 A DK 352077A DK 352077 A DK352077 A DK 352077A DK 352077 A DK352077 A DK 352077A
Authority
DK
Denmark
Prior art keywords
pyrrolidones
disubstituted
intermediates
procedure
preparation
Prior art date
Application number
DK352077A
Other languages
Danish (da)
English (en)
Inventor
A J Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK352077A publication Critical patent/DK352077A/da
Priority to DK472580A priority Critical patent/DK146179C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK352077A 1976-08-06 1977-08-05 Fremgangsmade til fremstilling af 1,5-disubstituerede 2-pyrrolidoner og mellemprodukter til anvendelse herved DK352077A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK472580A DK146179C (da) 1976-08-06 1980-11-07 1,5-disubstituerede 3ae-oxo-2-pyrrolidon-forbindelser til anvendelse som mellemprodukter ved fremstilling af 1,5-disubstituerede 2-pyrrolidon-forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
DK352077A true DK352077A (da) 1978-02-07

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK352077A DK352077A (da) 1976-08-06 1977-08-05 Fremgangsmade til fremstilling af 1,5-disubstituerede 2-pyrrolidoner og mellemprodukter til anvendelse herved

Country Status (31)

Country Link
JP (2) JPS5321159A (cs)
AR (1) AR217080A1 (cs)
AT (1) AT362887B (cs)
AU (1) AU508007B2 (cs)
BE (1) BE857506A (cs)
BG (1) BG31073A3 (cs)
CA (1) CA1077948A (cs)
CH (1) CH624934A5 (cs)
CS (1) CS221269B2 (cs)
DD (2) DD143768A5 (cs)
DE (1) DE2735904A1 (cs)
DK (1) DK352077A (cs)
ES (2) ES461388A1 (cs)
FI (1) FI70009C (cs)
FR (1) FR2369260A1 (cs)
GB (2) GB1556569A (cs)
GR (1) GR68688B (cs)
HU (1) HU180273B (cs)
IE (1) IE45505B1 (cs)
IL (1) IL52615A (cs)
LU (1) LU77936A1 (cs)
NL (1) NL7708637A (cs)
NO (1) NO772752L (cs)
NZ (1) NZ184806A (cs)
PH (1) PH17398A (cs)
PL (2) PL112931B1 (cs)
PT (1) PT66891B (cs)
SE (1) SE423813B (cs)
SU (3) SU703016A3 (cs)
YU (1) YU192577A (cs)
ZA (1) ZA774704B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
ATE327751T1 (de) * 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
NZ525164A (en) * 2000-11-27 2005-04-29 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis
IL159996A0 (en) * 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
AU2003207900A1 (en) * 2002-03-18 2003-09-29 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
US6573294B1 (en) 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1586564B1 (en) * 2003-01-21 2012-11-28 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT66891B (en) 1979-01-26
JPS5531147B2 (cs) 1980-08-15
GB1556569A (en) 1979-11-28
LU77936A1 (cs) 1978-04-27
FI70009C (fi) 1986-09-12
FI70009B (fi) 1986-01-31
PT66891A (en) 1977-09-01
NO772752L (no) 1978-02-07
GR68688B (cs) 1982-02-01
AU2751577A (en) 1979-02-08
ATA579477A (de) 1980-11-15
AR217080A1 (es) 1980-02-29
IL52615A0 (en) 1977-10-31
SU703016A3 (ru) 1979-12-05
NL7708637A (nl) 1978-02-08
IL52615A (en) 1981-09-13
AT362887B (de) 1981-06-25
NZ184806A (en) 1980-04-28
IE45505L (en) 1978-02-06
SE423813B (sv) 1982-06-07
IE45505B1 (en) 1982-09-08
JPS5321159A (en) 1978-02-27
CH624934A5 (cs) 1981-08-31
JPS5555161A (en) 1980-04-22
DD143768A5 (de) 1980-09-10
GB1556570A (en) 1979-11-28
ES461388A1 (es) 1978-12-01
DD136135A5 (de) 1979-06-20
FR2369260A1 (fr) 1978-05-26
CA1077948A (en) 1980-05-20
JPS585196B2 (ja) 1983-01-29
HU180273B (en) 1983-02-28
DE2735904A1 (de) 1978-02-09
PL200124A1 (pl) 1978-05-22
AU508007B2 (en) 1980-03-06
BG31073A3 (en) 1981-10-15
FI772376A (cs) 1978-02-07
FR2369260B1 (cs) 1982-02-12
BE857506A (fr) 1978-02-06
SU850000A3 (ru) 1981-07-23
PL112931B1 (en) 1980-11-29
PH17398A (en) 1984-08-08
ZA774704B (en) 1978-06-28
SE7708642L (sv) 1978-02-07
SU818480A3 (ru) 1981-03-30
YU192577A (en) 1983-04-30
ES471349A1 (es) 1979-09-16
CS221269B2 (en) 1983-04-29

Similar Documents

Publication Publication Date Title
DK13878A (da) Fremgangsmaade til fremstilling af 11beta-substituerede 4,9-diensteroider
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
DK498080A (da) Fremgangsmaade til fremstilling af 4!-epidaunorubicin, 3!,4!-diepidaunorubicin og disses doxorubicinanaloge
DK180878A (da) Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK445078A (da) Fremgangsmaade til fremstilling af 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyklisk arylimidazoler og derivater deraf
DK163379A (da) Fremgangsmaade til fremstilling af substituerede 1,3-diaryl-2-imino-imidazolidiner og 2-imino-hexahydro-pyrimidiner
DK13978A (da) Fremgangsmaade til fremstilling af 11betasubstituerede 1,3,5(,0)-triensteroider
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
DK352077A (da) Fremgangsmade til fremstilling af 1,5-disubstituerede 2-pyrrolidoner og mellemprodukter til anvendelse herved
DK117779A (da) Fremgangsmaade til fremstilling af 2,6-dialkoxybenzamider
DK185579A (da) Fremgangsmaade til fremstilling af n-(benzothienopyrazol)amider
DK465578A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner
DK483378A (da) Fremgangsmaade til fremstilling af 2,4-difluoranilin
DK187577A (da) Fremgangsmade til fremstilling af 1,4-benzodioxsnderivater
DK227277A (da) Fremgangsmade til fremstilling af 1,3-disubstituerede nitrosourinstoffer
DK328280A (da) Fremgangsmaade til fremstilling af 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazon og mellemprodukter herved
DK184377A (da) Fremgangsmade til fremstilling af indazolyl-(4)-oxy-propanolaminer
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK339378A (da) Fremgangsmaade til fremstilling af 1,3,5-s-hexahydrotrisubstituerede triaziner
DK267078A (da) Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf
DK548478A (da) Fremgangsmaade til fremstilling af 2,4,5-trichlorphenol
DK251178A (da) Fremgangsmaade til fremstilling af 9-hydroxyhexahydrodibenzo (b,d)pyraner og 1-substituerede -9-hydroxyhexahydrodibenzo (b,d)pyraner
NO149635C (no) Fremgangsmaate til fremstilling av 1,n-(omega-amino-alfa-hydroksyalkanoyl)-kanamycin a eller b
DK307378A (da) Fremgangsmaade til fremstilling af 1,2,4-oxadiazoler

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment